Log In
Print
BCIQ
Print
Print this Print this
 

RQ-00000009

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin 5HT-4 partial agonist
Molecular Target Serotonin (5-HT4) receptor
Mechanism of ActionSerotonin (5-HT4) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today